Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06773117 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment

StatusNot Yet Recruiting
PhasePhase 3
Started2025-09-01
View on ClinicalTrials.gov ↗

Amendment history

2025-08-14
Study Identification, Study Status, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations v1
Primary completion date2026-04-05→2027-05-31
Completion date2026-04-05→2027-12-31
Start date2025-02-01→2025-09-01
Study sites1→19
InterventionsExtremely-low dose Susu Xiao'er Zhike Granules (Drug), High dose Susu Xiao'er Zhike Granules (Drug)→Extremely-low dose Susu Xiao'er Zhike Granules (Drug), Susu Xiao'er Zhike Granules (Drug)
Eligibility criteria+39 characters
[...] and the severity VAS score of day or night cough was ≥40 mm ，the cough symptom score was ≥2 points; Conforming to the standard of wind-cold cough differentiat [...]
Secondary endpointsdetails revised at 1 of 9 entries
Study title-52 characters
Phase III Clinical Study on Efficacy y and SafetyTrial of Susu Zhike Granules forin Treating Acute Cough Due to Common ColdChildren With Cold-cough Syndrome infor ChildrenAcute Cough Treatment
2025-01-12
Original filing
To confirm the effect of Susu Xiaoer Zhike granules in treating cough caused by common cold (wind-cold cough Syndromes) in children aged 6\~13 years, shortening the course of disease and improving symptoms.
Trial Details
NCT Number NCT06773117
Lead Sponsor Tasly Pharmaceutical Group Co., Ltd
Conditions Cough
Enrollment 360 participants
Start Date 2025-09-01
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-19